

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 8.96889471 |
| 2 | lipoprotein transport (GO:0042953) | 7.40543986 |
| 3 | regulation of guanylate cyclase activity (GO:0031282) | 7.33961148 |
| 4 | intestinal absorption (GO:0050892) | 6.89364693 |
| 5 | regulation of bile acid biosynthetic process (GO:0070857) | 6.84124116 |
| 6 | NADH metabolic process (GO:0006734) | 6.51859889 |
| 7 | epoxygenase P450 pathway (GO:0019373) | 6.37926332 |
| 8 | fat-soluble vitamin biosynthetic process (GO:0042362) | 6.15576240 |
| 9 | positive regulation of guanylate cyclase activity (GO:0031284) | 5.69541703 |
| 10 | regulation of cellular extravasation (GO:0002691) | 5.55022917 |
| 11 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 5.44658319 |
| 12 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 5.44658319 |
| 13 | endocrine process (GO:0050886) | 5.44658319 |
| 14 | hormone catabolic process (GO:0042447) | 5.31371786 |
| 15 | virion attachment to host cell (GO:0019062) | 5.13353773 |
| 16 | adhesion of symbiont to host cell (GO:0044650) | 5.13353773 |
| 17 | maintenance of gastrointestinal epithelium (GO:0030277) | 5.09666457 |
| 18 | cellular glucuronidation (GO:0052695) | 4.98896771 |
| 19 | fructose metabolic process (GO:0006000) | 4.98233153 |
| 20 | regulation of systemic arterial blood pressure (GO:0003073) | 4.92778232 |
| 21 | glucuronate metabolic process (GO:0019585) | 4.89153973 |
| 22 | uronic acid metabolic process (GO:0006063) | 4.89153973 |
| 23 | drug metabolic process (GO:0017144) | 4.68136191 |
| 24 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.65458168 |
| 25 | peptide hormone processing (GO:0016486) | 4.60538939 |
| 26 | urea cycle (GO:0000050) | 4.58153189 |
| 27 | digestion (GO:0007586) | 4.51679781 |
| 28 | bile acid and bile salt transport (GO:0015721) | 4.48804260 |
| 29 | regulation of cGMP biosynthetic process (GO:0030826) | 4.43612743 |
| 30 | regulation of triglyceride catabolic process (GO:0010896) | 4.41531860 |
| 31 | antibacterial humoral response (GO:0019731) | 4.37578366 |
| 32 | adhesion of symbiont to host (GO:0044406) | 4.35457678 |
| 33 | diacylglycerol metabolic process (GO:0046339) | 4.35236218 |
| 34 | urea metabolic process (GO:0019627) | 4.34819444 |
| 35 | glycosphingolipid catabolic process (GO:0046479) | 4.26864466 |
| 36 | vitamin A metabolic process (GO:0006776) | 4.26702395 |
| 37 | glycolipid catabolic process (GO:0019377) | 4.24798877 |
| 38 | peptide catabolic process (GO:0043171) | 4.21951421 |
| 39 | antimicrobial humoral response (GO:0019730) | 4.20900578 |
| 40 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.19688012 |
| 41 | flavonoid metabolic process (GO:0009812) | 4.13897685 |
| 42 | regulation of vitamin metabolic process (GO:0030656) | 4.11589449 |
| 43 | nitrogen cycle metabolic process (GO:0071941) | 3.97635241 |
| 44 | renal system process involved in regulation of blood volume (GO:0001977) | 3.95607683 |
| 45 | drinking behavior (GO:0042756) | 3.90787962 |
| 46 | plasma lipoprotein particle assembly (GO:0034377) | 3.76508312 |
| 47 | alkaloid metabolic process (GO:0009820) | 3.71992969 |
| 48 | lipoprotein metabolic process (GO:0042157) | 3.70887172 |
| 49 | epithelial structure maintenance (GO:0010669) | 3.70469481 |
| 50 | digestive system process (GO:0022600) | 3.68218185 |
| 51 | regulation of cGMP metabolic process (GO:0030823) | 3.67744933 |
| 52 | drug catabolic process (GO:0042737) | 3.63587179 |
| 53 | positive regulation of pseudopodium assembly (GO:0031274) | 3.61611108 |
| 54 | cellular response to nitric oxide (GO:0071732) | 3.55474848 |
| 55 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.55200352 |
| 56 | vitamin transmembrane transport (GO:0035461) | 3.54805918 |
| 57 | arginine metabolic process (GO:0006525) | 3.51499428 |
| 58 | fat-soluble vitamin metabolic process (GO:0006775) | 3.48526024 |
| 59 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.48043091 |
| 60 | protein-lipid complex assembly (GO:0065005) | 3.47684361 |
| 61 | midgut development (GO:0007494) | 3.47499839 |
| 62 | regulation of cholesterol homeostasis (GO:2000188) | 3.47039672 |
| 63 | ceramide catabolic process (GO:0046514) | 3.46688804 |
| 64 | homocysteine metabolic process (GO:0050667) | 3.44890574 |
| 65 | mRNA modification (GO:0016556) | 3.42010693 |
| 66 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.41750988 |
| 67 | glycosylceramide metabolic process (GO:0006677) | 3.40229360 |
| 68 | exogenous drug catabolic process (GO:0042738) | 3.38207936 |
| 69 | bile acid metabolic process (GO:0008206) | 3.36197268 |
| 70 | vitamin transport (GO:0051180) | 3.34231654 |
| 71 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.31677865 |
| 72 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.31663201 |
| 73 | sulfate transmembrane transport (GO:1902358) | 3.31456954 |
| 74 | actin filament depolymerization (GO:0030042) | 3.28146599 |
| 75 | drug transport (GO:0015893) | 3.27172087 |
| 76 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.27003727 |
| 77 | regulation of pseudopodium assembly (GO:0031272) | 3.23271695 |
| 78 | sphingomyelin metabolic process (GO:0006684) | 3.22979421 |
| 79 | cGMP biosynthetic process (GO:0006182) | 3.20531689 |
| 80 | sphingolipid catabolic process (GO:0030149) | 3.19988998 |
| 81 | response to nitric oxide (GO:0071731) | 3.19681041 |
| 82 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.17988267 |
| 83 | cellular response to reactive nitrogen species (GO:1902170) | 3.17706606 |
| 84 | drug transmembrane transport (GO:0006855) | 3.17533923 |
| 85 | citrulline biosynthetic process (GO:0019240) | 3.16447194 |
| 86 | glycerol metabolic process (GO:0006071) | 3.15965215 |
| 87 | transcytosis (GO:0045056) | 3.15805002 |
| 88 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.15440893 |
| 89 | sexual reproduction (GO:0019953) | 3.14501767 |
| 90 | glomerulus development (GO:0032835) | 3.14329313 |
| 91 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.13632478 |
| 92 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.13445290 |
| 93 | cGMP-mediated signaling (GO:0019934) | 3.12114635 |
| 94 | auditory receptor cell differentiation (GO:0042491) | 3.07980883 |
| 95 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.06074724 |
| 96 | phospholipid efflux (GO:0033700) | 3.05370117 |
| 97 | membrane lipid catabolic process (GO:0046466) | 3.03540316 |
| 98 | vitamin biosynthetic process (GO:0009110) | 3.00268552 |
| 99 | negative regulation of steroid metabolic process (GO:0045939) | 2.99166349 |
| 100 | angiotensin maturation (GO:0002003) | 11.3957300 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 5.51473522 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.25628018 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.51918369 |
| 4 | GATA4_25053715_ChIP-Seq_YYC3_Human | 3.08361133 |
| 5 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.05505771 |
| 6 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.93238861 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.68428987 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.55797480 |
| 9 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.55434515 |
| 10 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.51216613 |
| 11 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.47948540 |
| 12 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.35238833 |
| 13 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.35103032 |
| 14 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.30272625 |
| 15 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.29931176 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 2.25691168 |
| 17 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.15091919 |
| 18 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.10764741 |
| 19 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 2.09399249 |
| 20 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.06845102 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.94725557 |
| 22 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.91461878 |
| 23 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.89885231 |
| 24 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.87353470 |
| 25 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.77308995 |
| 26 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.71553022 |
| 27 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.68145142 |
| 28 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.68111408 |
| 29 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.66370615 |
| 30 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.60521982 |
| 31 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.56152648 |
| 32 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.49846918 |
| 33 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.46765715 |
| 34 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.45077953 |
| 35 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.38481162 |
| 36 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.37266496 |
| 37 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.32832011 |
| 38 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.30141349 |
| 39 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.29873040 |
| 40 | GATA2_19941826_ChIP-Seq_K562_Human | 1.28052267 |
| 41 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26270559 |
| 42 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.25560422 |
| 43 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23990238 |
| 44 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.19457740 |
| 45 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.17602250 |
| 46 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.17566938 |
| 47 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13967876 |
| 48 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.11951090 |
| 49 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.10577912 |
| 50 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.08120742 |
| 51 | GATA1_19941826_ChIP-Seq_K562_Human | 1.08041405 |
| 52 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.07855939 |
| 53 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.07621188 |
| 54 | RXR_22108803_ChIP-Seq_LS180_Human | 1.06155363 |
| 55 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.05162084 |
| 56 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.97892123 |
| 57 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.96198261 |
| 58 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.95794582 |
| 59 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.95540660 |
| 60 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.95498520 |
| 61 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.95163373 |
| 62 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.94982192 |
| 63 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.94197093 |
| 64 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.94195505 |
| 65 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.93322109 |
| 66 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.92538055 |
| 67 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.92314803 |
| 68 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.91434561 |
| 69 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.91424519 |
| 70 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90834126 |
| 71 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.90822744 |
| 72 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.90818370 |
| 73 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.90442459 |
| 74 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.90178868 |
| 75 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.89742007 |
| 76 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.88335705 |
| 77 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86704309 |
| 78 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.85898964 |
| 79 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.85756416 |
| 80 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.83494154 |
| 81 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.82842206 |
| 82 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.82487366 |
| 83 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.81885847 |
| 84 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.81805716 |
| 85 | SA1_27219007_Chip-Seq_Bcells_Human | 0.81503133 |
| 86 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.81290294 |
| 87 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.81054403 |
| 88 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.80227947 |
| 89 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.79907320 |
| 90 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.79380474 |
| 91 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.79077723 |
| 92 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.78301617 |
| 93 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.76581521 |
| 94 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.76252011 |
| 95 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.74992040 |
| 96 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.71680956 |
| 97 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.70654275 |
| 98 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.70603785 |
| 99 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.70468682 |
| 100 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.70166945 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 8.82614628 |
| 2 | MP0001666_abnormal_nutrient_absorption | 4.82838027 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.81716493 |
| 4 | MP0003183_abnormal_peptide_metabolism | 4.68511384 |
| 5 | MP0004147_increased_porphyrin_level | 3.88358244 |
| 6 | MP0005365_abnormal_bile_salt | 3.73404489 |
| 7 | MP0004264_abnormal_extraembryonic_tissu | 3.57823943 |
| 8 | MP0002139_abnormal_hepatobiliary_system | 3.53534089 |
| 9 | MP0004019_abnormal_vitamin_homeostasis | 3.42390680 |
| 10 | MP0009379_abnormal_foot_pigmentation | 3.39783423 |
| 11 | MP0009840_abnormal_foam_cell | 3.01946277 |
| 12 | MP0010155_abnormal_intestine_physiology | 2.98099505 |
| 13 | MP0010234_abnormal_vibrissa_follicle | 2.89535885 |
| 14 | MP0003866_abnormal_defecation | 2.35668219 |
| 15 | MP0005409_darkened_coat_color | 2.12181533 |
| 16 | MP0001664_abnormal_digestion | 2.10737551 |
| 17 | MP0010329_abnormal_lipoprotein_level | 2.03706782 |
| 18 | MP0003868_abnormal_feces_composition | 1.85123933 |
| 19 | MP0005332_abnormal_amino_acid | 1.77061090 |
| 20 | MP0000490_abnormal_crypts_of | 1.74037722 |
| 21 | MP0009643_abnormal_urine_homeostasis | 1.72352875 |
| 22 | MP0003252_abnormal_bile_duct | 1.71147978 |
| 23 | MP0010352_gastrointestinal_tract_polyps | 1.65328450 |
| 24 | MP0005166_decreased_susceptibility_to | 1.58717968 |
| 25 | MP0000538_abnormal_urinary_bladder | 1.56524670 |
| 26 | MP0000477_abnormal_intestine_morphology | 1.54570439 |
| 27 | MP0001764_abnormal_homeostasis | 1.51274883 |
| 28 | MP0003806_abnormal_nucleotide_metabolis | 1.48188283 |
| 29 | MP0001873_stomach_inflammation | 1.41049749 |
| 30 | MP0001663_abnormal_digestive_system | 1.39354669 |
| 31 | MP0005670_abnormal_white_adipose | 1.39275428 |
| 32 | MP0001765_abnormal_ion_homeostasis | 1.39040585 |
| 33 | MP0000465_gastrointestinal_hemorrhage | 1.37335894 |
| 34 | MP0004858_abnormal_nervous_system | 1.34542093 |
| 35 | MP0002876_abnormal_thyroid_physiology | 1.33330023 |
| 36 | MP0001188_hyperpigmentation | 1.28934222 |
| 37 | MP0000678_abnormal_parathyroid_gland | 1.28502554 |
| 38 | MP0005636_abnormal_mineral_homeostasis | 1.27486386 |
| 39 | MP0001501_abnormal_sleep_pattern | 1.27022929 |
| 40 | MP0004782_abnormal_surfactant_physiolog | 1.21085978 |
| 41 | MP0002822_catalepsy | 1.16927216 |
| 42 | MP0002136_abnormal_kidney_physiology | 1.16920278 |
| 43 | MP0005381_digestive/alimentary_phenotyp | 1.14919636 |
| 44 | MP0004270_analgesia | 1.13405541 |
| 45 | MP0002118_abnormal_lipid_homeostasis | 1.11875574 |
| 46 | MP0003879_abnormal_hair_cell | 1.10873838 |
| 47 | MP0003718_maternal_effect | 1.09861987 |
| 48 | MP0004043_abnormal_pH_regulation | 1.09547275 |
| 49 | MP0000462_abnormal_digestive_system | 1.03625031 |
| 50 | MP0005448_abnormal_energy_balance | 1.01349518 |
| 51 | MP0000609_abnormal_liver_physiology | 0.95761533 |
| 52 | MP0005535_abnormal_body_temperature | 0.94786170 |
| 53 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.92481612 |
| 54 | MP0001845_abnormal_inflammatory_respons | 0.92268041 |
| 55 | MP0002396_abnormal_hematopoietic_system | 0.89093878 |
| 56 | MP0003300_gastrointestinal_ulcer | 0.88124677 |
| 57 | MP0002971_abnormal_brown_adipose | 0.86136534 |
| 58 | MP0002098_abnormal_vibrissa_morphology | 0.83210544 |
| 59 | MP0000230_abnormal_systemic_arterial | 0.82853953 |
| 60 | MP0001756_abnormal_urination | 0.80975515 |
| 61 | MP0005319_abnormal_enzyme/_coenzyme | 0.77497130 |
| 62 | MP0009785_altered_susceptibility_to | 0.76719439 |
| 63 | MP0003724_increased_susceptibility_to | 0.75580485 |
| 64 | MP0009115_abnormal_fat_cell | 0.74700581 |
| 65 | MP0002796_impaired_skin_barrier | 0.74683485 |
| 66 | MP0008469_abnormal_protein_level | 0.74211740 |
| 67 | MP0005451_abnormal_body_composition | 0.74074818 |
| 68 | MP0002166_altered_tumor_susceptibility | 0.74032774 |
| 69 | MP0000537_abnormal_urethra_morphology | 0.74007577 |
| 70 | MP0001485_abnormal_pinna_reflex | 0.72528324 |
| 71 | MP0004947_skin_inflammation | 0.68251099 |
| 72 | MP0006082_CNS_inflammation | 0.67180176 |
| 73 | MP0009642_abnormal_blood_homeostasis | 0.65991143 |
| 74 | MP0001835_abnormal_antigen_presentation | 0.65280748 |
| 75 | MP0000604_amyloidosis | 0.63374927 |
| 76 | MP0003329_amyloid_beta_deposits | 0.63062611 |
| 77 | MP0005025_abnormal_response_to | 0.63050604 |
| 78 | MP0003303_peritoneal_inflammation | 0.62523456 |
| 79 | MP0008875_abnormal_xenobiotic_pharmacok | 0.60333470 |
| 80 | MP0000249_abnormal_blood_vessel | 0.59235808 |
| 81 | MP0009764_decreased_sensitivity_to | 0.58636578 |
| 82 | MP0008872_abnormal_physiological_respon | 0.57538582 |
| 83 | MP0002138_abnormal_hepatobiliary_system | 0.57291931 |
| 84 | MP0002896_abnormal_bone_mineralization | 0.56809407 |
| 85 | MP0005666_abnormal_adipose_tissue | 0.56781479 |
| 86 | MP0003191_abnormal_cellular_cholesterol | 0.56260638 |
| 87 | MP0001790_abnormal_immune_system | 0.56022179 |
| 88 | MP0005387_immune_system_phenotype | 0.56022179 |
| 89 | MP0005501_abnormal_skin_physiology | 0.55000415 |
| 90 | MP0006138_congestive_heart_failure | 0.50676387 |
| 91 | MP0001881_abnormal_mammary_gland | 0.50669504 |
| 92 | MP0009333_abnormal_splenocyte_physiolog | 0.50178974 |
| 93 | MP0005165_increased_susceptibility_to | 0.49851486 |
| 94 | MP0005174_abnormal_tail_pigmentation | 0.49344439 |
| 95 | MP0005310_abnormal_salivary_gland | 0.49180698 |
| 96 | MP0003436_decreased_susceptibility_to | 0.48651836 |
| 97 | MP0002006_tumorigenesis | 0.48169199 |
| 98 | MP0003953_abnormal_hormone_level | 0.46171118 |
| 99 | MP0005334_abnormal_fat_pad | 0.45289411 |
| 100 | MP0002078_abnormal_glucose_homeostasis | 0.43284257 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hydroxyprolinuria (HP:0003080) | 7.36607947 |
| 2 | Abnormality of proline metabolism (HP:0010907) | 7.36607947 |
| 3 | Malnutrition (HP:0004395) | 7.12300164 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 5.89073978 |
| 5 | Chronic diarrhea (HP:0002028) | 5.73409712 |
| 6 | Ileus (HP:0002595) | 5.30385010 |
| 7 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 5.29391254 |
| 8 | Acanthocytosis (HP:0001927) | 5.22558266 |
| 9 | Fat malabsorption (HP:0002630) | 4.99174934 |
| 10 | Abnormality of vitamin B metabolism (HP:0004340) | 4.93722160 |
| 11 | Widely patent fontanelles and sutures (HP:0004492) | 4.50090100 |
| 12 | Confusion (HP:0001289) | 4.17358174 |
| 13 | Pigmentary retinal degeneration (HP:0001146) | 4.11104293 |
| 14 | Abnormality of vitamin metabolism (HP:0100508) | 3.91231166 |
| 15 | Hyperglycinuria (HP:0003108) | 3.80970937 |
| 16 | Hyperactive renin-angiotensin system (HP:0000841) | 3.68852953 |
| 17 | Systemic lupus erythematosus (HP:0002725) | 3.62755764 |
| 18 | Thin bony cortex (HP:0002753) | 3.52005878 |
| 19 | Abnormality of urine glucose concentration (HP:0011016) | 3.49782544 |
| 20 | Glycosuria (HP:0003076) | 3.49782544 |
| 21 | Nausea (HP:0002018) | 3.35311921 |
| 22 | Wide cranial sutures (HP:0010537) | 3.33264421 |
| 23 | Abdominal distention (HP:0003270) | 3.27101241 |
| 24 | Nephrolithiasis (HP:0000787) | 3.26639979 |
| 25 | Decreased circulating renin level (HP:0003351) | 3.25118123 |
| 26 | Congenital sensorineural hearing impairment (HP:0008527) | 3.17259510 |
| 27 | Abnormality of glycine metabolism (HP:0010895) | 3.15267495 |
| 28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.15267495 |
| 29 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.13539379 |
| 30 | Proximal tubulopathy (HP:0000114) | 3.10955340 |
| 31 | Metabolic alkalosis (HP:0200114) | 3.08185156 |
| 32 | Alkalosis (HP:0001948) | 3.04583253 |
| 33 | Steatorrhea (HP:0002570) | 2.94018253 |
| 34 | Right ventricular cardiomyopathy (HP:0011663) | 2.92576820 |
| 35 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.86843611 |
| 36 | Villous atrophy (HP:0011473) | 2.86843611 |
| 37 | Potter facies (HP:0002009) | 2.86026951 |
| 38 | Facial shape deformation (HP:0011334) | 2.86026951 |
| 39 | Xanthomatosis (HP:0000991) | 2.85786677 |
| 40 | Eczematoid dermatitis (HP:0000976) | 2.85424545 |
| 41 | Hypolipoproteinemia (HP:0010981) | 2.85060446 |
| 42 | Abnormality of renin-angiotensin system (HP:0000847) | 2.75347847 |
| 43 | Hypophosphatemia (HP:0002148) | 2.73561520 |
| 44 | Posterior subcapsular cataract (HP:0007787) | 2.72586241 |
| 45 | Megaloblastic anemia (HP:0001889) | 2.68277400 |
| 46 | Increased purine levels (HP:0004368) | 2.67987783 |
| 47 | Hyperuricemia (HP:0002149) | 2.67987783 |
| 48 | Enlarged epiphyses (HP:0010580) | 2.65171524 |
| 49 | Hyperammonemia (HP:0001987) | 2.64965724 |
| 50 | Hyperparathyroidism (HP:0000843) | 2.64148165 |
| 51 | Focal segmental glomerulosclerosis (HP:0000097) | 2.59895029 |
| 52 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.49412010 |
| 53 | Abnormality of purine metabolism (HP:0004352) | 2.46604252 |
| 54 | Hemorrhage of the eye (HP:0011885) | 2.45877300 |
| 55 | Delayed epiphyseal ossification (HP:0002663) | 2.39501931 |
| 56 | Abnormal glucose tolerance (HP:0001952) | 2.35489251 |
| 57 | Abnormal urine phosphate concentration (HP:0012599) | 2.34367384 |
| 58 | Hypotension (HP:0002615) | 2.33773130 |
| 59 | Poikilocytosis (HP:0004447) | 2.26148671 |
| 60 | Abnormality of the costochondral junction (HP:0000919) | 2.26089768 |
| 61 | Abnormality of nucleobase metabolism (HP:0010932) | 2.22654544 |
| 62 | Conjugated hyperbilirubinemia (HP:0002908) | 2.19389683 |
| 63 | Flat acetabular roof (HP:0003180) | 2.18973966 |
| 64 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.17419733 |
| 65 | Hyperphosphaturia (HP:0003109) | 2.17224980 |
| 66 | Epidermoid cyst (HP:0200040) | 2.16637861 |
| 67 | Hyperphosphatemia (HP:0002905) | 2.14873971 |
| 68 | Cerebral palsy (HP:0100021) | 2.14277388 |
| 69 | Gingivitis (HP:0000230) | 2.12695631 |
| 70 | Protuberant abdomen (HP:0001538) | 2.09586461 |
| 71 | Metabolic acidosis (HP:0001942) | 2.08767071 |
| 72 | Gastrointestinal dysmotility (HP:0002579) | 2.05009947 |
| 73 | Intrahepatic cholestasis (HP:0001406) | 2.02398471 |
| 74 | Subcapsular cataract (HP:0000523) | 2.02048246 |
| 75 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 10.6003853 |
| 76 | Pancreatitis (HP:0001733) | 1.97778092 |
| 77 | Abnormal biliary tract morphology (HP:0012440) | 1.97284613 |
| 78 | Glomerulosclerosis (HP:0000096) | 1.92697561 |
| 79 | Renal tubular acidosis (HP:0001947) | 1.89757574 |
| 80 | Abnormality of magnesium homeostasis (HP:0004921) | 1.87817450 |
| 81 | Gout (HP:0001997) | 1.85808886 |
| 82 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.84947818 |
| 83 | Dehydration (HP:0001944) | 1.84313355 |
| 84 | Irritability (HP:0000737) | 1.81447971 |
| 85 | Glomerulonephritis (HP:0000099) | 1.79912434 |
| 86 | Growth hormone excess (HP:0000845) | 1.77433095 |
| 87 | Multiple lipomas (HP:0001012) | 1.77006774 |
| 88 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.76534099 |
| 89 | Dicarboxylic aciduria (HP:0003215) | 1.76390373 |
| 90 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.76390373 |
| 91 | Biliary tract neoplasm (HP:0100574) | 1.75323939 |
| 92 | Nephritis (HP:0000123) | 1.75221331 |
| 93 | Hyperaldosteronism (HP:0000859) | 1.74828722 |
| 94 | Metaphyseal irregularity (HP:0003025) | 1.71599079 |
| 95 | Symptomatic seizures (HP:0011145) | 1.71315301 |
| 96 | Abnormal tarsal ossification (HP:0008369) | 1.70490290 |
| 97 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.70400635 |
| 98 | Abnormality of complement system (HP:0005339) | 1.68261741 |
| 99 | Peripheral demyelination (HP:0011096) | 1.67549489 |
| 100 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.66261049 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 7.90971225 |
| 2 | MST1R | 5.36821444 |
| 3 | ERN1 | 4.02767195 |
| 4 | RIPK1 | 3.68830722 |
| 5 | MAP3K10 | 3.51293310 |
| 6 | PRKG2 | 3.39045467 |
| 7 | STK39 | 3.05377294 |
| 8 | EPHA2 | 2.79272467 |
| 9 | OXSR1 | 2.37489014 |
| 10 | MET | 2.03474385 |
| 11 | FGFR4 | 1.84172258 |
| 12 | EPHA3 | 1.80691381 |
| 13 | TESK2 | 1.66601150 |
| 14 | MAP3K2 | 1.63039463 |
| 15 | TYK2 | 1.59016513 |
| 16 | EPHB2 | 1.57408196 |
| 17 | TNIK | 1.54415339 |
| 18 | MAP3K12 | 1.48200116 |
| 19 | PIK3CA | 1.46933014 |
| 20 | PTK6 | 1.45133677 |
| 21 | EPHB1 | 1.43380157 |
| 22 | LMTK2 | 1.35453839 |
| 23 | MST4 | 1.35079481 |
| 24 | PDK2 | 1.32504728 |
| 25 | DDR2 | 1.30756585 |
| 26 | STK24 | 1.18644137 |
| 27 | GRK6 | 1.17190271 |
| 28 | PRPF4B | 1.16315194 |
| 29 | FGFR3 | 1.13414280 |
| 30 | AKT3 | 1.13308403 |
| 31 | NLK | 1.05516017 |
| 32 | MATK | 1.04057775 |
| 33 | MAP4K1 | 1.03739595 |
| 34 | MYLK | 1.01780711 |
| 35 | MAP3K1 | 0.99159247 |
| 36 | RIPK4 | 0.96541913 |
| 37 | ERBB2 | 0.91434326 |
| 38 | CASK | 0.88336902 |
| 39 | MAP2K2 | 0.87331769 |
| 40 | EPHA4 | 0.86127099 |
| 41 | BMPR2 | 0.81269179 |
| 42 | CDC42BPA | 0.79949056 |
| 43 | PDPK1 | 0.77969972 |
| 44 | FER | 0.74133706 |
| 45 | IRAK1 | 0.73295360 |
| 46 | PRKAA2 | 0.72764060 |
| 47 | PIM1 | 0.70566962 |
| 48 | MAPK11 | 0.67081534 |
| 49 | TESK1 | 0.67036111 |
| 50 | MAP2K6 | 0.66686863 |
| 51 | PRKACG | 0.66417724 |
| 52 | JAK1 | 0.62555329 |
| 53 | TAOK1 | 0.60750208 |
| 54 | PDK1 | 0.59485070 |
| 55 | PRKCA | 0.54535060 |
| 56 | YES1 | 0.49308438 |
| 57 | DYRK1B | 0.49292673 |
| 58 | RET | 0.48539156 |
| 59 | PRKCZ | 0.48507007 |
| 60 | MAP3K11 | 0.45513325 |
| 61 | CAMK2D | 0.44818870 |
| 62 | SRC | 0.44445873 |
| 63 | FRK | 0.43906260 |
| 64 | PIK3CG | 0.43103501 |
| 65 | FYN | 0.42948221 |
| 66 | PDGFRA | 0.42151139 |
| 67 | PAK4 | 0.41583816 |
| 68 | JAK2 | 0.41327509 |
| 69 | CSK | 0.39146426 |
| 70 | ITK | 0.38912747 |
| 71 | MELK | 0.36407522 |
| 72 | PTK2 | 0.35812889 |
| 73 | PRKCD | 0.35108983 |
| 74 | GRK1 | 0.35057413 |
| 75 | MAP3K14 | 0.34768598 |
| 76 | TBK1 | 0.34556730 |
| 77 | BTK | 0.33624664 |
| 78 | IKBKE | 0.32452865 |
| 79 | CDK6 | 0.32237190 |
| 80 | ABL2 | 0.32215032 |
| 81 | KSR2 | 0.30860373 |
| 82 | TEC | 0.30284740 |
| 83 | SYK | 0.30116860 |
| 84 | CSF1R | 0.29259230 |
| 85 | BMX | 0.28089574 |
| 86 | NEK6 | 0.26618140 |
| 87 | MAP3K3 | 0.26542523 |
| 88 | CAMK2B | 0.26282941 |
| 89 | MAPKAPK2 | 0.26175903 |
| 90 | CAMK2G | 0.25871902 |
| 91 | JAK3 | 0.25301819 |
| 92 | ZAP70 | 0.22304728 |
| 93 | CDK19 | 0.21662461 |
| 94 | LYN | 0.21379631 |
| 95 | IGF1R | 0.20521410 |
| 96 | IRAK4 | 0.19346548 |
| 97 | KIT | 0.18629467 |
| 98 | LCK | 0.16755626 |
| 99 | MAP3K5 | 0.15068416 |
| 100 | PRKCQ | 0.14980564 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 5.11446235 |
| 2 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 4.39411128 |
| 3 | Fat digestion and absorption_Homo sapiens_hsa04975 | 4.24363032 |
| 4 | Renin-angiotensin system_Homo sapiens_hsa04614 | 4.15311992 |
| 5 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.67620716 |
| 6 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.67050993 |
| 7 | Mineral absorption_Homo sapiens_hsa04978 | 2.60241195 |
| 8 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.54131098 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.48015742 |
| 10 | Histidine metabolism_Homo sapiens_hsa00340 | 2.26202766 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.25740256 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.24887854 |
| 13 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.19591851 |
| 14 | Galactose metabolism_Homo sapiens_hsa00052 | 2.07779684 |
| 15 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.95264923 |
| 16 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.89944210 |
| 17 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.89223590 |
| 18 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.88603119 |
| 19 | Retinol metabolism_Homo sapiens_hsa00830 | 1.87894203 |
| 20 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.86138989 |
| 21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.83744902 |
| 22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.81074063 |
| 23 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.77058434 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.74209468 |
| 25 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.74202404 |
| 26 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.62628760 |
| 27 | Bile secretion_Homo sapiens_hsa04976 | 1.62454420 |
| 28 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.49578144 |
| 29 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.49375478 |
| 30 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.48558847 |
| 31 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.39816212 |
| 32 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.32298809 |
| 33 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.26712216 |
| 34 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.25565766 |
| 35 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.22186084 |
| 36 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.15581222 |
| 37 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.12038090 |
| 38 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.08339269 |
| 39 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.04872206 |
| 40 | Asthma_Homo sapiens_hsa05310 | 1.01817919 |
| 41 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.00789705 |
| 42 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.83205376 |
| 43 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.82832524 |
| 44 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.81952503 |
| 45 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.79402379 |
| 46 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.77213566 |
| 47 | Allograft rejection_Homo sapiens_hsa05330 | 0.73529973 |
| 48 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.68105746 |
| 49 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.65150837 |
| 50 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.62668265 |
| 51 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.61164550 |
| 52 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.56392019 |
| 53 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.55116587 |
| 54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.52202048 |
| 55 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50236491 |
| 56 | Renin secretion_Homo sapiens_hsa04924 | 0.48682143 |
| 57 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.48275474 |
| 58 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.47264246 |
| 59 | Peroxisome_Homo sapiens_hsa04146 | 0.43809263 |
| 60 | ABC transporters_Homo sapiens_hsa02010 | 0.36971592 |
| 61 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.35217345 |
| 62 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.33910247 |
| 63 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.33501169 |
| 64 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.32878892 |
| 65 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.32488660 |
| 66 | Insulin resistance_Homo sapiens_hsa04931 | 0.32482626 |
| 67 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31103519 |
| 68 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.29956712 |
| 69 | Other glycan degradation_Homo sapiens_hsa00511 | 0.26702839 |
| 70 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.26626409 |
| 71 | Leishmaniasis_Homo sapiens_hsa05140 | 0.26544383 |
| 72 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.22123906 |
| 73 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.21150199 |
| 74 | Cocaine addiction_Homo sapiens_hsa05030 | 0.20104913 |
| 75 | Hepatitis C_Homo sapiens_hsa05160 | 0.19663590 |
| 76 | Metabolic pathways_Homo sapiens_hsa01100 | 0.16409585 |
| 77 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.15363742 |
| 78 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.14555823 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.12960849 |
| 80 | Pertussis_Homo sapiens_hsa05133 | 0.12168297 |
| 81 | Tight junction_Homo sapiens_hsa04530 | 0.11739657 |
| 82 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.10854760 |
| 83 | Insulin secretion_Homo sapiens_hsa04911 | 0.10445616 |
| 84 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.10395068 |
| 85 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.09337864 |
| 86 | Viral myocarditis_Homo sapiens_hsa05416 | 0.09135983 |
| 87 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.08837611 |
| 88 | Carbon metabolism_Homo sapiens_hsa01200 | 0.08738351 |
| 89 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.07794481 |
| 90 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.07522594 |
| 91 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.06901714 |
| 92 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.06348076 |
| 93 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.05678674 |
| 94 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.05654570 |
| 95 | Amoebiasis_Homo sapiens_hsa05146 | 0.02231983 |
| 96 | Sulfur relay system_Homo sapiens_hsa04122 | 0.02228742 |
| 97 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.02084869 |
| 98 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.02055214 |
| 99 | Influenza A_Homo sapiens_hsa05164 | 0.01014078 |
| 100 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.0002372 |

